Study suggests neurofilament levels may be used as a marker of damage to brain cells in MS
Use of oral hormonal contraceptive drugs does not appear to be associated with greater risk of relapses
People diagnosed with CIS who received early treatment are less likely to convert to MS
A biomarker in cerebrospinal fluid is associated with a higher risk of MS in people with CIS
Early treatment of clinically isolated syndrome shows beneficial effects for relapse rate and cognitive functioning
MS comes in several forms, including clinically isolated syndrome, relapsing-remitting MS, secondary progressive MS and primary progressive MS.